BiotechTube
RevaTis

RevaTis

Liège, Belgium· Est.
revatis.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.5M

Overview

Revatis is a private, preclinical-stage biotech leveraging a proprietary platform to isolate and expand mesenchymal stem cells (MSCs) from a small muscle biopsy. Its core business model spans both therapeutic applications in veterinary medicine and a service/provider role for human biomedical research, including biobanking, organ-on-a-chip, and 3D bioprinting. Founded in 2015, the company operates with GMP-certified production, has an international footprint, and is built on strong IP from its academic founders. It is currently pre-revenue, focusing on technology development and partnership expansion.

Musculoskeletal DisordersRegenerative Medicine

Technology Platform

Patented platform for isolating and expanding multipotent adult mesenchymal stem cells (MSCs) from a minimally invasive muscle micro-biopsy, with GMP-certified manufacturing.

Funding History

1
Total raised:$2.5M
Seed$2.5M

Opportunities

The rapidly growing veterinary regenerative medicine market offers a near-term path for autologous therapies.
Simultaneously, the booming demand for high-quality human cells in advanced research (organ-on-a-chip, 3D bioprinting) provides a parallel B2B revenue stream and establishes the company's technical credibility.

Risk Factors

Key risks include the challenge of achieving commercial adoption in competitive veterinary and research tool markets, the need for continuous funding as a pre-revenue entity, and the scientific/regulatory hurdles inherent in demonstrating consistent efficacy and safety for cell-based products.

Competitive Landscape

Revatis competes with other MSC therapy developers in veterinary medicine (e.g., VetStem, Medrego) and numerous cell suppliers in human research. Its differentiation hinges on its specific muscle-derived MSC source, minimally invasive biopsy technique, and integrated GMP manufacturing platform.

More companies in Cell & Gene Therapy →More companies in Belgium →